Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal estradiol pretreatment to improve colposcopic diagnosis in postmenopausal women with cervical dysplasia
2022-000269-42Phase 4Active
- Sponsor
- Randers Regional Hospital
- Start
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, double-blind trial of estradiol in cervical dysplasia (CIN) and cervical intraepithelial neoplasia (CIN) (2 arms), sponsored by Randers Regional Hospital. Started Feb 2022; status: active.
02
Drugs
estradiol
03
Conditions
cervical dysplasia (CIN)cervical intraepithelial neoplasia (CIN)
Beyond the preview
Go deeper on 2022-000269-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000269-42.